Oral Chinese medicinal composition for treating virus myocarditis

A technology of viral myocarditis and composition, which is applied in the field of oral Chinese medicine composition, and can solve problems such as inconvenient taking, backward dosage form, and unsatisfactory curative effect

Active Publication Date: 2005-08-24
SHANGHAI PHARMA GRP QINGDAO GROWFUL PHARMA CO LTD
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The clinical focus is on immunosuppressants and modulators, non-steroidal anti-inflammatory drugs, antiviral drugs and their combination therapy, but the efficacy is not satisfactory
[0004] To the medical treatment of viral myocarditis, research a lot in recent years, especially traditional Chinese medicine medicine h

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0021] Prescription: Astragalus 330g, Ophiopogon japonicus 220g, Angelica 220g, Baishao 220g, Chuanxiong 110g, Salvia miltiorrhiza 110g, safflower 56g, honeysuckle 220g, Daqingye 220g, Pueraria 110g, Fangfeng 110g, Citrus aurantium 110g, Licorice 110g

[0022] Preparation method: according to the technical scheme of the present invention, add 4 times of water to extract volatile oil from Angelica, Rhizoma Chuanxiong, Fructus Fructus Fructus Fructus Citrus Fructus Fructus Aurantii, and filter the aqueous solution. It is 1.15 (50 ℃), for later use. Astragalus, Danshen, honeysuckle, and kudzu root were extracted with 60% ethanol under reflux, and 5, 4, and 3 times the amount of alcohol were added in sequence. The first time was 2 hours, the second time, and the third time were 1.5 hours each. The extracts were combined and filtered. The filtrate is used for later use. Combine the other five flavors such as Ophiopogon japonicus with the above two kinds of medicinal residues, add ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An orally taken Chinese medicing for treating viral myocarditis is prepared from 7 Chinese-medicinal materials including astragalus root, Chinese angelica roto, white peony root, Chuan-xiong rhizome, etc.

Description

technical field [0001] The invention relates to an oral Chinese medicine composition, in particular to an oral Chinese medicine composition for treating viral myocarditis. Background technique [0002] The morbidity and mortality of cardiovascular system diseases are the first among all system diseases. Viral myocarditis is acute or chronic inflammation of the myocardium caused by viral infection, which seriously endangers human health, especially adolescents, children and adults. Due to the wide application of antibiotics, the incidence of rheumatic myocarditis has decreased significantly, while the incidence of viral myocarditis has increased significantly. In the past ten years, the incidence has increased by nearly ten times, and it has become one of the common diseases of the cardiovascular system. The fatality rate was 2.8%-12%, 5% had scars caused by myocarditis, 15%-20% had abnormal electrocardiogram within five years, and 5% developed card...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61P9/00A61P31/12
Inventor 姜作玲黄庆文
Owner SHANGHAI PHARMA GRP QINGDAO GROWFUL PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap